SGS acquires the M-Scan group
SGS group has acquired M-Scan, a group of chemical analysis laboratories specializing in advanced chemical and biochemical testing.
SGS group has acquired M-Scan, a group of chemical analysis laboratories specializing in advanced chemical and biochemical testing as well as high-end GLP/GMP contract analytical services, consultancy and training based on mass spectrometry and chromatography.
"This acquisition clearly complements our vision to become one of the top players within the biologics testing arena (large molecules) said Chris Kirk, CEO of SGS. "The acquisition of M-Scan is a milestone in the implementation of our strategy to take advantage of the on-going, high-growth development of vaccines and monoclonal antibodies. M-Scan's global recognition and expertise together with its geographic footprint combined with the existing advanced analytical services in SGS Life Science provides an excellent platform for further growth and development.“
The M-Scan group currently consists of four laboratories supported by marketing offices in Europe together with agents in Korea, India and Singapore. It provides analytical services in the area of life science, including protein/glycoprotein analysis, pharmaceutical analysis, extractables/leachables and bioanalysis to support the drug development programme.
For further information, visit www.sgs.com
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
